🇺🇸 FDA
Patent

US 9526799

Low density lipoprotein receptor-mediated siRNA delivery

granted A61KA61K31/7088A61K31/713

Quick answer

US patent 9526799 (Low density lipoprotein receptor-mediated siRNA delivery) held by Arrowhead Pharmaceuticals, Inc. expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arrowhead Pharmaceuticals, Inc.
Grant date
Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/7088, A61K31/713, A61K38/16, A61K47/64